| BTP BTP
 | 57227-09-5 | In-house | Tiropramide Intermediate | Commercialized | 
                            
                    | RV-142 RV-142
 | 84611-22-3 | In-house | Erdosteine Intermediate | Commercialized | 
                            
                    | 라우로일라이신 N-Lauroyl-L-lysine
 | 52315-75-0 | In-house | Cosmetic Ingredient | Commercialized | 
                            
                    | PDRN PDRN (polydeoxyribonucleotide)
 | 100403-24-5 | 50 ~ 1,500 kDa | Repairing, anti-inflamation, anti-aging | Commercialized. DMF be finished by Mid of 2026
 | 
                            
                    | PN PN (polynucleotide)
 | 100403-24-5 | 100 ~ 2,000 kDa | Repairing, anti-inflamation, anti-aging | Commercialized. DMF be finished by Mid of 2026
 | 
                            
                    | PDLLA PDLLA (Poly(DL-lactic acid))
 | 26680-10-4, 51056-13-9 | 0.16~2.7 dl/g | Microsphere used for medical beauty filler | Commercialized |